ICICI Lombard Q2 FY27 Earnings Call: PAT Jumps 27.5%, Retail Health Surges 66.4% (ICICIGI)

ICICI Lombard General Insurance Company Ltd held its Q2 FY27 earnings call on October 14, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.

Strong Q2 Profitability Masks Softer H1

• PAT grew 27.5% YoY to Rs.10.31 billion in Q2 FY 2026-2027 (vs. Rs.8.09 billion in Q2 FY 2025-2026), but H1 FY 2026-2027 PAT degrew 5.8% to Rs.14.54 billion (vs. Rs.15.43 billion in H1 FY 2025-2026).
• PBT rose 27.8% to Rs.13.59 billion in Q2 FY 2026-2027 (vs. Rs.10.63 billion), while H1 FY 2026-2027 PBT degrew 5.8% to Rs.19.21 billion.
• Q2 FY 2026-2027 combined ratio was 104.5% (vs. 103.9% in Q2 FY 2025-2026); ex-CAT it was 102.7% (vs. 102.6%), with CAT losses of Rs.1.18 billion vs. Rs.0.73 billion a year earlier.
• Investment income rose to Rs.15.54 billion in Q2 FY 2026-2027 (vs. Rs.12.49 billion), with capital gains of Rs.4.53 billion (vs. Rs.2.36 billion); investment assets reached Rs.643.32 billion at Sep 30, 2026.
• Q2 FY 2026-2027 ROE was 23.7% (vs. 21.3%); H1 FY 2026-2027 return on average equity was 16.8% (vs. 20.7%). Solvency stood at 2.74x (Sep 30, 2026).
• Interim dividend of Rs.7 per share declared for H1 FY 2026-2027 (vs. Rs.6.5 for H1 FY 2025-2026).

Outpacing the Industry; Health Surge, Motor Leadership

• Q2 FY 2026-2027 GDPI grew 13.9% vs. industry 13.2% (industry figure excludes crop and mass health); industry GDPI grew 8.9% in H1 FY 2026-2027 vs. ICICI Lombard's 5.4%.
• Health grew 26.8% in H1 FY 2026-2027 (industry: 21%), with retail health surging 66.4% (industry: 32%) to reach 5% market share by September 2026.
• Motor portfolio grew 13% in H1 FY 2026-2027, maintaining market leadership at 10.3% share; motor combined ratio of 108.3% vs. industry 131.4% in Q1 FY 2026-2027 widened the delta to 23.1 percentage points.
• Market share gains in Q2 FY 2026-2027 vs. Q2 FY 2025-2026 in Fire (11.9%), Marine Cargo (19%), Engineering (16.4%) and Liability (16.6%); fire degrowth moderated to 21.2% in Q2 from 32.1% in Q1 FY 2026-2027.
• Commercial segment recovered from Q1 FY 2026-2027 lows — management attributed the Q1 FY 2026-2027 commercial loss ratio of 118% to exceptional large losses, with Q2 FY 2026-2027 ratios moderating as these events did not recur.
• EV contribution to the motor book is 7-8% in FY 2026-2027, with OD loss ratios broadly in line with the non-EV book.

Discipline Intact, But CAT and TP Severity Linger

• Motor loss ratio guided at 65-67% for FY 2026-2027 — H1 FY 2026-2027 came in at 65.4% (vs. 66.6% in H1 FY 2025-2026), within the guided band.
• Motor TP loss ratio rose ~2,000 bps sequentially in Q2 FY 2026-2027 due to long-tail claim development; CFO confirmed the Rs.1.65 billion Supreme Court verdict provision was booked in Q1 FY 2026-2027 with no further reserve anticipated as of Q2 FY 2026-2027.
• CAT losses aggregated to Rs.118 crores in Q2 FY 2026-2027 (vs. Rs.74-75 crores in Q2 FY 2025-2026), driving motor OD loss ratio deterioration YoY due to severe flooding; ex-CAT, OD loss ratios were sequentially better than Q1 FY 2026-2027.
• Group health loss ratio was 97.9% in Q2 FY 2026-2027 (vs. 93.7% in Q2 FY 2025-2026, ~99.9% in Q1 FY 2026-2027); retail health indemnity loss ratio was 64.6%, within the guided 65-70% comfort range.
• CV mix maintained within a 20-25% band of the motor portfolio in H1 FY 2026-2027, with ROE-driven underwriting; analyst Nidesh (Investec) flagged the risk of the Supreme Court verdict increasing CV claims severity against TP pricing stagnant for the past 3 years — management did not directly address this in the response.
• Industry motor combined ratio of 131% in Q1 FY 2026-2027 was described by management as unsustainable and not workable, with a market correction expected.

IRDAI Reforms and GST Council Moves Reshape the Field

• IRDAI's consultation paper 'Recalibrating Economics of Insurance Distribution' was cited by management as a catalyst for an "industry-wide reboot"; the CEO called the draft distribution reforms a "landmark change" and noted the regulator's wish is 100% binding on the company.
• Management believes the paper's objectives align with the long-term "insurance for all" vision, and cited "government targeting 100% insurance penetration by 2047" as the long-term policy backdrop.
• Proposed 25% expense of management (EOM) cap seen as a benefit — ICICI Lombard has historically kept EOM within 30% and remains compliant annually, while competitors operating above 30% face cost reduction pressure.
• GST Council (Oct 2026) recommended removing ITC restrictions on employer-sponsored group health and life insurance to improve affordability.
• Net impact on TP tariffs is uncertain at this early stage — the CEO acknowledged the reforms are deflationary for third-party costs but court judgments are inflationary; the final economic impact is subject to regulator feedback and the company will abide by the final outcome.

GenAI Gains, Digital Sourcing Push, Omnichannel Play

• GenAI adoption improved fraud trigger precision to 60% from 45% in H1 FY 2026-2027; 73% of customer interactions were handled via digital DIY journeys (vs. 39% in FY 2025-2026).
• Digital sourcing target of 15%, up from the current 6% (target horizon unspecified).
• IL TakeCare app reached 23.3 million downloads by Q2 FY 2026-2027 end; app-processed claims grew 25.6% to 378,583 in H1 FY 2026-2027, and 99.2% of health claims were paid within 30 days in H1 FY 2026-2027.
• 25 innovative solutions launched for the Silver Jubilee, including new retail health product 'Vibe' for Gen Z; small-ticket products (warranty extension, mobile insurance) leverage the multi-product, multi-channel platform with an omnichannel strategy.
• Banca contributed 12.5-15% of total premium on a full-year basis via corporate agency distribution (banks, NBFCs, FIs); outside ICICI, the contribution is single digit. Reinsurance accepted book remains single-digit annually, written only when underwriting sense is met.
• Retail retention improved 3-5% in H1 FY 2026-2027 vs. H1 FY 2025-2026 (also 3-5% in FY 2025-2026 per April guidance); management views IRDAI's distribution reforms as supportive of the renewal thrust.

H2 Momentum, With Volatility Caveats

• Earned premium momentum expected to continue in H2 FY 2026-2027 (Q3 and Q4), with management highlighting Q3 FY 2026-2027 as a seasonally strong quarter for the general insurance industry.
• Optimism for motor opportunities in Q3 FY 2026-2027, supported by historic highs in new vehicle sales driving H1 FY 2026-2027 momentum; a base effect from prior GST reforms is expected from Q3 FY 2026-2027.
• Management expressed optimism for H2 FY 2026-2027 commercial lines, citing industry-wide losses driving disciplined underwriting, but cautioned that commercial lines remain exposed to event volatility.
• CAT losses in Q2 FY 2026-2027 treated as business as usual, with a higher threshold than peers and expected to average out over four quarters.
• Q1 FY 2026-2027 IFRS financials were filed with the regulator by September 30, 2026; CFO Gopal Balachandran cautioned against making relative comparisons between IFRS and IGAP reporting standards.
• Group health loss ratios guided to improve sequentially in corporate health as efficiencies continue (period unspecified beyond the ongoing trajectory).